| LCEPDA BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1689642 14 Aug 2014 | on 13 Aug 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use relating to metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents. | | | LCEPEEN NORDIC IMMOTECH APS (A DANISH PRIVATE LIMITED COMPANY)
1256394 28 Apr 2005 | on 14 Mar 2024 | Class 005 Class 005 Pharmaceutical Products Algae extracts used for the manufacturing of nutraceuticals and dietary and nutritional supplements, health foods, food additives. | | 
